中外制药宣布10月1日起人事变动：吉田真希、佐野洋子出任部门负责人

Personnel Changes

AI 导读

中外制药宣布自2026年10月1日起进行人事调整，吉田真希出任制药技术部门分析开发部负责人，此前任该部门生物制品分析副负责人；佐野洋子出任项目生命周期管理单元专科生命周期管理部负责人，此前任该部门神经科学疾病领域战略组负责人。

正文

TOKYO, September 14, 2026 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes, effective October 1, 2026.

[Details of Personnel Changes]
Department Heads

Name	New Responsibilities	Current Responsibilities
Maki Yoshida	Head of Analytical Development Dept., Pharmaceutical Technology Division	Deputy Head of Analytical Development Dept. (Bio Product Analysis), Pharmaceutical Technology Division
Yoko Sano	Head of Specialty Lifecycle Management Dept., Project Lifecycle Management Unit	Head of Neuroscience Disease Area Strategy Group, Specialty Lifecycle Management Dept., Project Lifecycle Management Unit